. Author manuscript; available in PMC: 2014 Apr 1.

Published in final edited form as: Neurosci Res. 2013 Mar 5;75(4):331–339. doi: 10.1016/j.neures.2013.02.005

Table 3.

Clinical Measures

		Group
		PMD	NPMD	Controls	Significance
HAMD-21	Men	28.09 (4.35)	25.00 (4.34)	0.73 (1.01)
	Women	32.22 (3.46)	23.08 (2.47)	0.45 (0.52)
	Total	29.95 (4.41)	23.68 (3.18)	0.59 (0.80)	PMD>NPMD^a NPMD>HC^a PMD>HC^a
BPRS	Men	28.64 (7.90)	15.00 (1.41)	0.45 (0.82)
	Women	33.89 (7.61)	15.38 (3.28)	0.09 (0.30)
	Total	31.00 (8.03)	15.26 (2.79)	0.27 (0.63)	PMD>NPMD^a NPMD>HC^a PMD>HC^a
Positive Symptoms	Men	7.73 (3.61)	0.17 (0.41)	0.00 (0.00)
	Women	11.00 (4.44)	0.08 (0.28)	0.00 (0.00)
	Total	9.20 (4.24)	0.11 (0.32)	0.00 (0.00)	PMD>NPMD^a PMD>HC^a

Table lists means (standard deviations) for participants’ clinical evaluations for Hamilton Depression Rating Scale 21-item (HAMD-21), the Brief Psychiatric Rating Scale (BPRS), and the positive symptom subscale of the BPRS. Data is organized by total group means and group by gender means.

p < 0.001.